Stay updated with breaking news from Codexis Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codexis (NASDAQ:CDXS – Get Free Report) and LanzaTech Global (NASDAQ:LNZA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Insider & Institutional Ownership 88.0% of Codexis shares […]
Codexis (NASDAQ:CDXS – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.04, Briefing.com reports. Codexis had a negative net margin of 41.17% and a negative return on equity of 32.75%. The company had revenue of […]
Codexis (NASDAQ:CDXS – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.04, Briefing.com reports. Codexis had a negative net margin of 41.17% and a negative return on equity of 32.75%. The company had revenue of […]
Codexis (NASDAQ:CDXS – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.04, Briefing.com reports. The firm had revenue of $21.32 million for the quarter, compared to analysts’ expectations of $19.83 million. Codexis had a negative net margin of […]
StockNews.com lowered shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. A number of other research analysts have also recently commented on the stock. Stephens reissued an overweight rating and issued a $6.00 target price on shares of Codexis […]